Butterfly Network (NYSE:BFLY – Get Free Report) and Haemonetics (NYSE:HAE – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.
Profitability
This table compares Butterfly Network and Haemonetics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Butterfly Network | -43.56% | -21.60% | -14.25% |
| Haemonetics | 7.52% | 27.42% | 9.77% |
Earnings & Valuation
This table compares Butterfly Network and Haemonetics”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Butterfly Network | $123.25 million | 13.18 | -$77.06 million | ($0.21) | -28.93 |
| Haemonetics | $1.33 billion | 4.20 | $97.31 million | $2.23 | 55.23 |
Haemonetics has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
37.8% of Butterfly Network shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 22.0% of Butterfly Network shares are owned by insiders. Comparatively, 2.1% of Haemonetics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Butterfly Network and Haemonetics, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Butterfly Network | 1 | 1 | 5 | 1 | 2.75 |
| Haemonetics | 0 | 3 | 8 | 1 | 2.83 |
Butterfly Network presently has a consensus target price of $8.75, suggesting a potential upside of 44.03%. Haemonetics has a consensus target price of $129.00, suggesting a potential upside of 4.74%. Given Butterfly Network’s higher possible upside, research analysts clearly believe Butterfly Network is more favorable than Haemonetics.
Volatility and Risk
Butterfly Network has a beta of 2.16, indicating that its share price is 116% more volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500.
Summary
Haemonetics beats Butterfly Network on 10 of the 14 factors compared between the two stocks.
About Butterfly Network
Butterfly Network develops portable ultrasound technology for healthcare professionals. Its handheld devices use the company’s semiconductor-based Ultrasound-on-Chip technology to produce ultrasound images and connect with compatible mobile devices, offering an alternative to larger, cart-based systems. The company’s products include the Butterfly iQ line of handheld ultrasound devices, along with software and cloud-based tools for viewing, managing and sharing medical images. Its offerings are designed for use across a range of clinical settings and applications.
About Haemonetics
Haemonetics Corporation is a global medical technology company focused on blood and plasma collection, processing and management. Its products and services are used by plasma collection organizations, blood centers and hospitals. The company provides automated plasma collection systems and related software and supplies, as well as technologies for collecting and processing blood components. Its hospital offerings include devices for surgical blood salvage and tools that help clinicians assess blood clotting and guide transfusion decisions.
Receive News & Ratings for Butterfly Network Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Butterfly Network and related companies with MarketBeat.com's FREE daily email newsletter.
